Hémangioendothéliome épithélioïde associé à une hyperplasie nodulaire régénérative
Georgia Malamut(Délégation Paris 5), Gilles Pelletier(Hôpital Paul-Brousse), Viseth Kuoch, Jean‐Paul Joly, Pierre Bédossa(Régie Autonome des Transports Parisiens (France)), Gabriel Perlemuter(Inserm), Catherine Buffet, Magali Colombat(Centre Hospitalier Universitaire de Toulouse)
Gastroentérologie Clinique et Biologique
February 29, 2008
Cited by 0
Related Papers
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k